Pacira BioSciences, Inc. PCRX Proceeds from secured term loan
Proceeds from secured term loan at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSecuredDebt.
The official record: Pacira BioSciences, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s proceeds from secured term loan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s proceeds from secured term loan?
- Pacira BioSciences, Inc. (PCRX) reported proceeds from secured term loan of $0 in Q4 2025.
- What is the long-term trend for Pacira BioSciences, Inc.'s proceeds from secured term loan?
- Over 2 years (2023 to 2025), Pacira BioSciences, Inc.'s proceeds from secured term loan has grown at a -100.0% compound annual growth rate (CAGR), from $149.55M to $0.
- What does proceeds from secured term loan mean?
- Cash proceeds received from the issuance of debt instruments that are backed by specific company assets as collateral. This metric indicates the company's ability to access secured credit markets to fund operations or strategic initiatives.